Literature DB >> 2821170

Expression of the infectious bronchitis virus spike protein by recombinant vaccinia virus and induction of neutralizing antibodies in vaccinated mice.

F M Tomley1, A P Mockett, M E Boursnell, M M Binns, J K Cook, T D Brown, G L Smith.   

Abstract

A cDNA clone of the infectious bronchitis virus (IBV) spike protein gene has been recombined into vaccinia virus. Cells infected with the recombinant virus synthesized IBV spike antigen which was recognized by antibody raised against purified spike protein. Immunofluorescence showed that the IBV spike antigen was transported to the infected cell surface membrane and immunoprecipitation showed the presence of the glycosylated 180K mol. wt. polypeptide precursor of the two spike subunits S1 and S2 that comigrated with this antigen from IBV-infected cells. Vaccinated mice produced antibody that recognized the IBV spike antigen by ELISA and which neutralized IBV infectivity as shown by ciliostasis tests on tracheal organ cultures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821170     DOI: 10.1099/0022-1317-68-9-2291

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Targeting vaccinia virus-expressed secretory beta subunit of human chorionic gonadotropin to the cell surface induces antibodies.

Authors:  J Srinivasan; O Singh; S Chakrabarti; G P Talwar
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

2.  Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly.

Authors:  H Vennema; L Heijnen; A Zijderveld; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

Review 3.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

4.  Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus.

Authors:  E J Hogervorst; L Schouls; J P Wagenaar; C J Boog; W J Spaan; J D van Embden; W van Eden
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes.

Authors:  Ji-Yong Zhou; Jian-Xiang Wu; Li-Qin Cheng; Xiao-Juan Zheng; Hui Gong; Shao-Bin Shang; En-Min Zhou
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 6.  Progress and challenges toward the development of vaccines against avian infectious bronchitis.

Authors:  Faruku Bande; Siti Suri Arshad; Mohd Hair Bejo; Hassan Moeini; Abdul Rahman Omar
Journal:  J Immunol Res       Date:  2015-04-14       Impact factor: 4.818

7.  Repeated avian infectious bronchitis virus infections within a single chicken farm.

Authors:  Atsushi Kato; Shiori Oguro; Yukino Kurihara; Hiroe Kojima; Yujin Inayoshi; Zhifeng Lin; Chihiro Sasakawa; Kazumoto Shibuya
Journal:  J Vet Med Sci       Date:  2019-03-04       Impact factor: 1.267

8.  Analysis of the S spike (peplomer) glycoprotein of bovine coronavirus synthesized in insect cells.

Authors:  D Yoo; M D Parker; L A Babiuk
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

9.  Coronavirus immunogens.

Authors:  L J Saif
Journal:  Vet Microbiol       Date:  1993-11       Impact factor: 3.293

Review 10.  Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.

Authors:  Dave Cavanagh
Journal:  Avian Pathol       Date:  2003-12       Impact factor: 3.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.